Results 11 to 20 of about 1,772,507 (392)

Psoriasis: To Vaccinate or Not to Vaccinate? [PDF]

Cureus, 2021
Psoriasis is a chronic, inflammatory, autoimmune disease characterized by red, dry, itchy, and scaly patches of abnormal skin growth on the elbows, knees, and/or scalp, which can negatively impact a patient's quality of life and activities of daily living.
Marc M Kesselman, Michelle Demory Beckler, Poonam Patel, Christian Summa   +3 more
openaire   +3 more sources

Acknowledgment to Reviewers of Vaccines in 2021

Vaccines, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Vaccines Editorial Office
doaj   +1 more source

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

New England Journal of Medicine, 2022
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), have been used since December 2020 in the United Kingdom.
N. Andrews, E. Tessier, J. Stowe, C. Gower, Freja C M Kirsebom, R. Simmons, E. Gallagher, S. Thelwall, N. Groves, G. Dabrera, R. Myers, C. Campbell, G. Amirthalingam, Matt Edmunds, M. Zambon, K. Brown, S. Hopkins, M. Chand, S. Ladhani, M. Ramsay, J. Lopez Bernal   +20 more
semanticscholar   +1 more source

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

British medical journal, 2021
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the UK variant of concern B.1.1.7), admissions to hospital, and deaths.
J. Lopez Bernal, N. Andrews, C. Gower, C. Robertson, J. Stowe, E. Tessier, R. Simmons, S. Cottrell, R. Roberts, M. O’Doherty, K. Brown, C. Cameron, D. Stockton, J. McMenamin, M. Ramsay   +14 more
semanticscholar   +1 more source

Expression of Concern: Artigas-Jerónimo et al. A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model. Vaccines 2020, 8, 77

Vaccines, 2020
The Editorial Office of Vaccines has decided to issue the following Expression of Concern about the published paper: A Novel Combined Scientific and Artistic Approach for the Advanced Characterization of Interactomes: The Akirin/Subolesin Model [...]
Vaccines Editorial Office
doaj   +1 more source

Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.

Asian Pacific Journal of Allergy and Immunology, 2020
As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS.
E. Prompetchara, C. Ketloy, T. Palaga
semanticscholar   +1 more source

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Journal of Hematology & Oncology, 2022
Research on tumor immunotherapy has made tremendous progress in the past decades, with numerous studies entering the clinical evaluation. The cancer vaccine is considered a promising therapeutic strategy in the immunotherapy of solid tumors.
Jian Liu, Minyang Fu, Manni Wang, Dandan Wan, Yuquan Wei, Xiawei Wei   +5 more
semanticscholar   +1 more source

Next-Generation TB Vaccines: Progress, Challenges, and Prospects

Vaccines, 2023
Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB), is a prevalent global infectious disease and a leading cause of mortality worldwide. Currently, the only available vaccine for TB prevention is Bacillus Calmette–Guérin (BCG).
Zhuang Li, Zhaoyang Ye, Linsheng Li, Ling Yang, W. Gong   +4 more
semanticscholar   +1 more source

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic

Vaccines, 2023
We are currently approaching three years since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday life, public health, and the global economy. Thus far, the vaccine has worked better
C. Chakraborty, M. Bhattacharya, K. Dhama   +2 more
semanticscholar   +1 more source

A research agenda for malaria eradication: vaccines. [PDF]

PLoS Medicine, 2011
Vaccines could be a crucial component of efforts to eradicate malaria. Current attempts to develop malaria vaccines are primarily focused on Plasmodium falciparum and are directed towards reducing morbidity and mortality.
malERA Consultative Group on Vaccines
doaj   +1 more source